151 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
152 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
153 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
154 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
155 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:15-cv-00149 |
N.D.W.Va. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
156 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
157 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
158 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
159 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
160 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
161 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
162 |
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00999 |
D.Del. |
|
|
|
|
163 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
164 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
165 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
166 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
167 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
168 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
169 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
170 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
171 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
172 |
Cosmo Technologies Limited et al v. Mylan Pharmaceuticals Inc. |
1:16-cv-00040 |
N.D.W.Va. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
173 |
Gilead Sciences Inc. v. Mylan Pharmaceuticals Inc. |
1:16-cv-00192 |
D.Del. |
|
|
|
|
174 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
175 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
176 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
177 |
Takeda Pharmaceuticals U.S.A, Inc. v. Mylan Pharmaceuticals, Inc. |
1:16-cv-00202 |
N.D.W.Va. |
|
|
|
|
178 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
179 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
180 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
181 |
Forest Laboratories, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:16-cv-01114 |
D.Del. |
|
|
|
|
182 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00187 |
D.Del. |
|
|
|
|
183 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00036 |
N.D.W.Va. |
|
|
|
|
184 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
185 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
186 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
187 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
188 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
189 |
Indivior Inc. et al v. Mylan Technologies Inc. et al |
1:17-cv-00157 |
N.D.W.Va. |
|
|
|
|
190 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
191 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
192 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
193 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
194 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
195 |
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. |
1:17-cv-01728 |
D.Del. |
|
|
|
|
196 |
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc. |
1:17-cv-00217 |
N.D.W.Va. |
|
|
|
|
197 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
198 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
199 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
200 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|